Pictet-Biotech HI/ LU0328682074 /
| NAV2/1/2023 | Chg.+3.9301 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 543.3400EUR | +0.73% | reinvestment | Equity Worldwide | Pictet AM (EU) ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2007 | - | - | - | - | - | - | - | - | - | - | - | -5.30 | - |
| 2008 | -3.13 | -2.60 | 1.08 | 3.03 | 2.75 | -0.86 | 15.44 | -3.78 | -6.64 | -15.26 | -10.61 | 8.87 | -14.39% |
| 2009 | 1.95 | -9.87 | 3.67 | -7.33 | 2.01 | 7.32 | 5.69 | -2.69 | 4.86 | -11.08 | 4.14 | 3.13 | -0.46% |
| 2010 | 1.60 | -0.70 | 5.24 | 0.19 | -14.54 | -5.60 | 5.86 | -2.81 | 10.79 | 3.05 | -2.58 | 9.74 | +7.76% |
| 2011 | -0.93 | 1.37 | 3.96 | 5.17 | -0.72 | -2.32 | -2.74 | -12.06 | -5.91 | 7.53 | 0.27 | 0.31 | -7.33% |
| 2012 | 9.32 | -0.24 | 5.05 | 2.03 | -0.93 | 8.50 | 1.63 | -0.03 | 4.58 | -7.84 | 4.44 | -1.59 | +26.46% |
| 2013 | 7.49 | 0.50 | 7.50 | 6.62 | 2.83 | -4.26 | 12.11 | -0.02 | 8.65 | -5.10 | 7.39 | 2.10 | +54.45% |
| 2014 | 9.27 | 7.18 | -10.09 | -7.01 | 1.62 | 7.88 | -2.27 | 8.12 | -1.68 | 8.34 | 2.58 | 0.03 | +23.97% |
| 2015 | 6.40 | 5.45 | 1.68 | -4.76 | 11.18 | 1.88 | 3.29 | -9.35 | -10.36 | 5.03 | 3.08 | 0.13 | +11.97% |
| 2016 | -22.19 | -6.14 | 4.23 | 3.17 | 4.20 | -7.98 | 12.22 | -4.59 | 1.82 | -10.87 | 7.48 | -3.69 | -24.27% |
| 2017 | 6.61 | 7.16 | -0.97 | 1.81 | -4.38 | 9.27 | 2.64 | 4.72 | -0.19 | -6.84 | -0.25 | 2.27 | +22.71% |
| 2018 | 6.59 | -5.36 | -2.38 | -3.73 | 4.00 | 1.17 | 3.59 | 3.44 | -1.64 | -13.82 | 2.06 | -10.06 | -16.84% |
| 2019 | 14.47 | 4.16 | -1.43 | -3.80 | -4.22 | 8.34 | 0.19 | -5.72 | -5.83 | 7.84 | 13.27 | 0.22 | +27.75% |
| 2020 | -4.33 | -2.41 | -4.40 | 17.30 | 5.28 | 1.96 | -1.12 | 0.26 | 5.86 | -3.40 | 7.12 | 3.94 | +26.86% |
| 2021 | 3.76 | -3.07 | -4.04 | 1.70 | -4.61 | 4.25 | -1.78 | 4.58 | -3.23 | -2.16 | -6.15 | 2.32 | -8.84% |
| 2022 | -18.63 | -2.47 | 3.44 | -9.90 | -4.08 | 4.48 | 5.98 | 4.53 | -2.31 | 1.88 | 4.31 | -3.10 | -17.39% |
| 2023 | 2.50 | 0.73 | - | - | - | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 17.87% | 25.63% | 30.68% | 27.87% | 25.81% |
| Sharpe ratio | 2.63 | 0.59 | 0.00 | -0.06 | -0.11 |
| Best month | +2.50% | +4.53% | +5.98% | +17.30% | +17.30% |
| Worst month | -3.10% | -3.10% | -9.90% | -18.63% | -18.63% |
| Maximum loss | -2.78% | -13.44% | -24.63% | -46.69% | -46.69% |
| Outperformance | -5.02% | - | -3.06% | -6.07% | -17.05% |
All quotes in EUR
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Pictet-Biotech I | reinvestment | 889.2100 | +9.47% | +10.32% | |
| Pictet-Biotech HI | reinvestment | 543.3400 | +2.56% | +2.23% | |
| Pictet-Biotech I dy | paying dividend | 786.2900 | +16.04% | +15.07% | |
| Pictet-Biotech Z | reinvestment | 1,079.0200 | +7.07% | +12.12% | |
| Pictet-Biotech I | reinvestment | 968.9200 | +6.02% | +8.85% | |
| Pictet-Biotech P dy | paying dividend | 813.4400 | +5.08% | +6.01% | |
| Pictet-Biotech R | reinvestment | 703.7700 | +4.35% | +3.82% | |
| Pictet-Biotech R | reinvestment | 645.4800 | +7.74% | +5.18% | |
| Pictet-Biotech P dy | paying dividend | 659.7200 | +15.01% | +12.01% | |
| Pictet-Biotech HP | reinvestment | 620.2100 | +1.41% | -1.09% | |
| Pictet-Biotech HP | reinvestment | 510.6900 | +1.64% | -0.49% | |
| Pictet-Biotech P | reinvestment | 746.4500 | +8.49% | +7.40% | |
| Pictet-Biotech HR | reinvestment | 441.5900 | +0.93% | -2.56% | |
| Pictet-Biotech P | reinvestment | 813.7300 | +5.08% | +6.01% |
Performance
| YTD | +3.24% | ||
|---|---|---|---|
| 6 Months | +8.56% | ||
| 1 Year | +2.56% | ||
| 3 Years | +2.23% | ||
| 5 Years | -1.61% | ||
| 10 Years | +91.00% | ||
| Since start | +110.38% | ||
| Year | |||
| 2022 | -17.39% | ||
| 2021 | -8.84% | ||
| 2020 | +26.86% | ||
| 2019 | +27.75% | ||
| 2018 | -16.84% | ||
| 2017 | +22.71% | ||
| 2016 | -24.27% | ||
| 2015 | +11.97% | ||
| 2014 | +23.97% | ||